HMDS is a laboratory specialising in the diagnosis of haematological malignancies which includes leukaemia, lymphoma and myeloma. The laboratory provides a comprehensive diagnostic service to the Yorkshire Cancer Network and The Yorkshire Coast and the Humber Cancer Network as well as receiving referrals from across the UK. HMDS also acts as a diagnostic reference centre for many national and international clinical trials.
There are over 60 recognised subtypes of haematological malignancy. These differ in their clinical presentation, the requirement for treatment and prognosis. Some patients may require little or no active treatment and have a normal life expectancy whereas others are treated with intensive chemotherapy, radiotherapy or bone marrow transplantation. Even within individual subtypes, there is often a wide variation in the response to treatment and survival. This places a premium on accurate diagnosis, prognostic assessment and disease monitoring during and after treatment.
HMDS uses multiple techniques in combinations appropriate to the clinical problem and the type of sample. Ensuring that there is internal consistency between the results obtained using various techniques is a key step in ensuring accuracy of diagnosis. Further information on the techniques HMDS utilise can be found here and details on how to send us a sample are found here.